Additive Orthopaedics
A medical technology company specializing in 3D-printed, patient-specific orthopedic implants and surgical solutions for complex foot and ankle reconstructions.
- CEO / Founder
- Greg Kowalczyk
- Team Size
- 11-50
- Stage
- Acquired
- Total Funding
- $1.0M
- Latest Round
- Acquired
- Key Investors
- NJ CoVest Fund
Technology & Products
Key Products
FDA-cleared 3D-printed Patient Specific Talus Spacer, Patient Specific 3D Printed Bone Segments, Patient Specific 3D Printed Plates, Patient Specific 3D Printed Osteotomy Wedge System, 3D Printed Digital Fusion Implant, and proprietary 'Locking Lattice' technology.
Technological Advantage
Proprietary 'Locking Lattice' technology that integrates porous titanium structures into custom-fit implants, designed to promote superior osseointegration (bone ingrowth) while matching the patient's unique anatomy via CT/MRI data.
Differentiation
Value Proposition
Provides anatomically precise, patient-specific solutions for complex deformities and bone loss where standard off-the-shelf implants are insufficient, leveraging 3D printing to improve surgical accuracy and patient outcomes.
How They Differentiate
Pioneered the first FDA-cleared patient-specific talus spacer and utilizes a proprietary 'Locking Lattice' technology designed specifically for complex limb salvage and bone ingrowth in foot and ankle procedures.
Market & Competition
Target Customers
Orthopedic surgeons, podiatric surgeons, foot and ankle specialists, and specialized surgical hospitals.
Industry Verticals
["Medical Devices","Orthopedics","Additive Manufacturing (3D Printing)","Healthcare"]
Competitors
Axial3D, OrthAlign, Monogram
Growth & Milestones
Growth Metrics
Acquired by DJO Global (now Enovis) in 2021 to anchor their foot and ankle reconstruction portfolio; technology now integrated into a multi-billion dollar public healthcare enterprise.
Major Milestones
["First 3D printed foot and ankle implant surgery performed in 2016","Received first-of-its-kind FDA 510(k) clearance for the Patient-Specific Talus Spacer in 2020","Acquired by DJO Global (Enovis) in January 2021","Strategic asset sale of certain product lines to Paragon 28 in 2021"]
Notable Customers
Hospital for Special Surgery (HSS); Duke University Health System; Cleveland Clinic